Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1993-11-29
pubmed:abstractText
The 2-aryl-indole-3-acetamide derivatives, 2-hexyl-indole-3-acetamide (FGIN-1-27) and 2-hexyl-indole-3-acetamide-N-benzene-tricarboxylic acid (FGIN-1-44) displaced [3H]1-(2-chlorophenyl)-N-methyl-N-(1- methylpropyl)-3-isoquinoline-carboxamide([3H]PK 11195) and [3H]4-chlorodiazepam ([3H]4'CD) from binding sites located on the rat brain mitochondrial DBI receptor complex (MDRC) with Ki values in the nanomolar range. Both 2-aryl-indole-3-acetamide derivatives acted as agonists at the MDRC and thereby stimulated the rate of pregnenolone synthesis in isolated rat brain mitochondria; this effect was inhibited by PK 11195, an MDRC ligand that does not possess steroidogenic activity. FGIN-1-27 and FGIN-1-44 failed to bind to other transmitter receptors, including gamma-aminobutyric-A receptors. When administered orally to rats, both FGIN-1-27 and FGIN-1-44 reduced fear of novelty in the elevated plus maze test. This action was prevented by PK 11195, but not by flumazenil. FGIN-1-44, which was rapidly converted to FGIN-1-27 in the rat brain, was 3 to 4 times more potent than FGIN-1-27 in reducing fear of novelty because of its greater bioavailability. FGIN-1-27 increased the brain pregnenolone content in adrenalectomized-castrated rats pretreated with trilostane (in order to prevent metabolism of pregnenolone to progesterone). This increase was blocked by pretreatment with PK 11195. Although FGIN-1-27 and FGIN-1-44 increased the corticosterone concentration in adrenal glands and plasma of hypophysectomized rats in a PK 11195-sensitive manner, both drugs failed to increase adrenal steroidogenesis in sham-operated rats.(ABSTRACT TRUNCATED AT 250 WORDS)
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/4'-chlorodiazepam, http://linkedlifedata.com/resource/pubmed/chemical/Benzodiazepinones, http://linkedlifedata.com/resource/pubmed/chemical/Carrier Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Corticosterone, http://linkedlifedata.com/resource/pubmed/chemical/Diazepam Binding Inhibitor, http://linkedlifedata.com/resource/pubmed/chemical/Indoleacetic Acids, http://linkedlifedata.com/resource/pubmed/chemical/Isoquinolines, http://linkedlifedata.com/resource/pubmed/chemical/N,N-di-n-hexyl-2-(4-fluorophenyl)ind..., http://linkedlifedata.com/resource/pubmed/chemical/PK 11195, http://linkedlifedata.com/resource/pubmed/chemical/Pregnenolone, http://linkedlifedata.com/resource/pubmed/chemical/Steroids, http://linkedlifedata.com/resource/pubmed/chemical/Tricarboxylic Acids
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0022-3565
pubmed:author
pubmed:issnType
Print
pubmed:volume
267
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
462-71
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:8229777-Adrenal Glands, pubmed-meshheading:8229777-Adrenalectomy, pubmed-meshheading:8229777-Animals, pubmed-meshheading:8229777-Behavior, Animal, pubmed-meshheading:8229777-Benzodiazepinones, pubmed-meshheading:8229777-Binding, Competitive, pubmed-meshheading:8229777-Brain, pubmed-meshheading:8229777-Carrier Proteins, pubmed-meshheading:8229777-Corticosterone, pubmed-meshheading:8229777-Diazepam Binding Inhibitor, pubmed-meshheading:8229777-Indoleacetic Acids, pubmed-meshheading:8229777-Isoquinolines, pubmed-meshheading:8229777-Male, pubmed-meshheading:8229777-Mitochondria, pubmed-meshheading:8229777-Orchiectomy, pubmed-meshheading:8229777-Pregnenolone, pubmed-meshheading:8229777-Rats, pubmed-meshheading:8229777-Rats, Sprague-Dawley, pubmed-meshheading:8229777-Solubility, pubmed-meshheading:8229777-Steroids, pubmed-meshheading:8229777-Tricarboxylic Acids
pubmed:year
1993
pubmed:articleTitle
Stimulation of brain steroidogenesis by 2-aryl-indole-3-acetamide derivatives acting at the mitochondrial diazepam-binding inhibitor receptor complex.
pubmed:affiliation
Fidia-Georgetown Institute for the Neurosciences, Washington, District of Columbia.
pubmed:publicationType
Journal Article, In Vitro, Research Support, U.S. Gov't, P.H.S.